about
Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virusHerpes Simplex Virus Type 2 Glycoprotein G Is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of Virus Attachment to CellsAnti-herpes simplex virus activities of two novel disulphated cyclitols.Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1.The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.The anterior commissure is a pathway for contralateral spread of herpes simplex virus type 1 after olfactory tract infection.Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity.Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells.Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate.Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain.The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus.Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan InteractionScreening and evaluation of anti-respiratory syncytial virus compounds in cultured cells.Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.Two novel fusion inhibitors of human respiratory syncytial virus.Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain.A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus.Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate.Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells.Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants.Mode of interaction between pseudorabies virus and heparan sulfate/heparin.Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate.Heparan sulfate and viral tropism.Involvement of viral glycoprotein gC-1 in expression of the selectin ligand sialyl-Lewis X induced after infection with herpes simplex virus type 1.Hemagglutination by herpes simplex virus type 1.An evaluation of a hemagglutination-inhibition test for the detection of antibodies to herpes simplex virus type 1.The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC.Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate.Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).
P50
Q21131361-6228A761-6132-42AF-B727-4D1ACBE34851Q27485008-631595F7-257B-4F28-9769-BC82165EE7F6Q33260475-C880B415-CCA3-42E1-958D-DA23953BF26DQ33544041-5B8E30CB-6F21-4BAA-9B83-8B76A2C35636Q36571976-C942341E-D9C5-4BFF-979E-03D9EDAE0708Q38301603-568DB92A-970B-424B-9820-E5B8B1D6BF53Q38308566-2BC958C5-847D-4BD3-8379-591CDD7A50C1Q38323484-404DDB3D-B21E-4E2D-AFBF-6F7F0D3EE849Q38330120-6DE508FD-96B6-49D8-8A06-EF82EFBE9E43Q38339095-D5DF04E6-F144-4012-BA32-165FEA0737DDQ38340116-489DCE2B-87D8-42D7-940A-4F11147764BEQ38854789-76A4E621-3276-4F72-94C9-F5135EEA3C2EQ39131314-C2C1DF63-DE93-4EEE-842B-A9B00FB2D40BQ39539848-A877C783-3ED7-4735-B8F1-DF6E278FCB3DQ39641415-09A7BC28-0C27-4021-BF1E-068DAF8E33F6Q39736541-F74FCB3F-4C62-42FF-B2FC-E0E62D420653Q39736609-1EF1C69C-B0BD-468B-B7E3-F6AD58AD89BAQ39986233-AED701C1-8E22-4FBE-98D4-FE49FFB7A05EQ40558490-14A003F0-1E72-484E-B678-9158580E481EQ40588204-FA9B38FE-5E68-42A9-B408-82CF202FEBFEQ40688796-E000E64B-5EC1-4E97-BA57-4E0E43CE8207Q40755419-AC09DADA-CF01-4EA1-96ED-E6D1374C9668Q40761467-2681E8F1-C6BD-4618-BBD2-7EB6C5B196DDQ41211802-189D61A5-9E30-4B97-B2A4-1E9DEEFAEA20Q41479052-1902BF6D-4B4B-46E3-B029-1A08A3BE6601Q42985321-7C270423-8997-434C-98A5-BEECC92C2D97Q43826193-2B73D817-3491-4327-9E88-4ACA6E58706EQ45159492-BCBDC231-5448-4148-8E48-0C791E929F0CQ45545241-0FCEE6D6-258C-4009-9E30-5196870CC90FQ45751832-4C795CD8-9024-43D1-BA97-F7C834C7873EQ46363054-DE8A7E01-AE8B-406A-A4EC-466271F19F15Q46860348-6E0223A7-045F-4404-9688-019AA1FAC4C7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Edward Trybala
@ast
Edward Trybala
@en
Edward Trybala
@es
Edward Trybala
@nl
Edward Trybala
@sl
type
label
Edward Trybala
@ast
Edward Trybala
@en
Edward Trybala
@es
Edward Trybala
@nl
Edward Trybala
@sl
prefLabel
Edward Trybala
@ast
Edward Trybala
@en
Edward Trybala
@es
Edward Trybala
@nl
Edward Trybala
@sl
P106
P21
P31
P496
0000-0003-2384-2123